BACKGROUND: Selectins are adhesion molecules that are expressed by the vascular endothelium upon activation and may be an imaging target for detecting myocardial ischemia long after resolution. The aim of this study was to test the hypothesis that molecular imaging of selectins with myocardial contrast echocardiographic (MCE) molecular imaging could be used to detect recent brief ischemia in closed-chest nonhuman primates. METHODS: Myocardial ischemia was produced in anesthetized adult rhesus macaques (n = 6) by percutaneous balloon catheter occlusion of the left anterior descending or circumflex coronary artery for 5 to 10 min. Three separate macaques served as nonischemic controls. MCE perfusion imaging was performed during coronary occlusion to measure risk area and at 100 to 110 min to exclude infarction. MCE molecular imaging was performed at 30 and 90 min after reperfusion using a lipid microbubble bearing dimeric recombinant human P-selectin glycoprotein ligand-1 (MB-YSPSL). Collection of blood for safety data, electrocardiography, and echocardiography were performed at baseline and before and 10 min after each MB-YSPSL injection. RESULTS: Vital signs, oxygen saturation, electrocardiographic results, ventricular systolic function, pulmonary vascular resistance, and serum safety markers were unchanged by intravenous injection of MB-YSPSL. On echocardiography, left ventricular dysfunction in the risk area had resolved by 30 min, and there was no evidence of infarction on MCE perfusion imaging. On selectin-targeted MCE molecular imaging, signal enhancement was greater (P < .05) in the risk area than remote territory at 30 min (25 ± 11 vs 11 ± 4 IU) and 90 min (13 ± 3 vs 3 ± 2 IU) after ischemia. There was no enhancement (<1 IU) in control nonischemic subjects. CONCLUSIONS: In primates, MCE molecular imaging of selectins using MB-YSPSL, a recombinant ligand appropriate for humans, is both safe and effective for imaging recent myocardial ischemia. This technique may be useful for detecting recent ischemia in patients with chest pain even in the absence of necrosis.
BACKGROUND: Selectins are adhesion molecules that are expressed by the vascular endothelium upon activation and may be an imaging target for detecting myocardial ischemia long after resolution. The aim of this study was to test the hypothesis that molecular imaging of selectins with myocardial contrast echocardiographic (MCE) molecular imaging could be used to detect recent brief ischemia in closed-chest nonhuman primates. METHODS:Myocardial ischemia was produced in anesthetized adult rhesus macaques (n = 6) by percutaneous balloon catheter occlusion of the left anterior descending or circumflex coronary artery for 5 to 10 min. Three separate macaques served as nonischemic controls. MCE perfusion imaging was performed during coronary occlusion to measure risk area and at 100 to 110 min to exclude infarction. MCE molecular imaging was performed at 30 and 90 min after reperfusion using a lipid microbubble bearing dimeric recombinant humanP-selectin glycoprotein ligand-1 (MB-YSPSL). Collection of blood for safety data, electrocardiography, and echocardiography were performed at baseline and before and 10 min after each MB-YSPSL injection. RESULTS: Vital signs, oxygen saturation, electrocardiographic results, ventricular systolic function, pulmonary vascular resistance, and serum safety markers were unchanged by intravenous injection of MB-YSPSL. On echocardiography, left ventricular dysfunction in the risk area had resolved by 30 min, and there was no evidence of infarction on MCE perfusion imaging. On selectin-targeted MCE molecular imaging, signal enhancement was greater (P < .05) in the risk area than remote territory at 30 min (25 ± 11 vs 11 ± 4 IU) and 90 min (13 ± 3 vs 3 ± 2 IU) after ischemia. There was no enhancement (<1 IU) in control nonischemic subjects. CONCLUSIONS: In primates, MCE molecular imaging of selectins using MB-YSPSL, a recombinant ligand appropriate for humans, is both safe and effective for imaging recent myocardial ischemia. This technique may be useful for detecting recent ischemia in patients with chest pain even in the absence of necrosis.
Authors: J H Pope; T P Aufderheide; R Ruthazer; R H Woolard; J A Feldman; J R Beshansky; J L Griffith; H P Selker Journal: N Engl J Med Date: 2000-04-20 Impact factor: 91.245
Authors: Flordeliza S Villanueva; Erxiong Lu; Shivani Bowry; Sevgi Kilic; Eric Tom; Jianjun Wang; Joan Gretton; John J Pacella; William R Wagner Journal: Circulation Date: 2007-01-08 Impact factor: 29.690
Authors: Howard Leong-Poi; Jonathan Christiansen; Peter Heppner; Christopher W Lewis; Alexander L Klibanov; Sanjiv Kaul; Jonathan R Lindner Journal: Circulation Date: 2005-06-13 Impact factor: 29.690
Authors: Yoichi Inaba; Brian P Davidson; Sajeevani Kim; Ya Ni Liu; William Packwood; J Todd Belcik; Aris Xie; Jonathan R Lindner Journal: J Am Soc Echocardiogr Date: 2013-12-04 Impact factor: 5.251
Authors: Nicholas G Fisher; Jonathan P Christiansen; Alexander Klibanov; Ronald P Taylor; Sanjiv Kaul; Jonathan R Lindner Journal: J Am Coll Cardiol Date: 2002-08-21 Impact factor: 24.094
Authors: David Brieger; Kim A Eagle; Shaun G Goodman; P Gabriel Steg; Andrzej Budaj; Kami White; Gilles Montalescot Journal: Chest Date: 2004-08 Impact factor: 9.410
Authors: Brian P Davidson; James Hodovan; Michael E Layoun; Harsh Golwala; Firas Zahr; Jonathan R Lindner Journal: J Am Coll Cardiol Date: 2021-11-16 Impact factor: 24.094
Authors: Vahagn Ohanyan; Liya Yin; Raffi Bardakjian; Christopher Kolz; Molly Enrick; Tatevik Hakobyan; John Kmetz; Ian Bratz; Jordan Luli; Masaki Nagane; Nadeem Khan; Huagang Hou; Periannan Kuppusamy; Jacqueline Graham; Frances Kwan Fu; Danielle Janota; Moses O Oyewumi; Suzanna Logan; Jonathan R Lindner; William M Chilian Journal: Circ Res Date: 2015-07-29 Impact factor: 17.367
Authors: Samantha M Fix; A Gloria Nyankima; Morgan D McSweeney; James K Tsuruta; Samuel K Lai; Paul A Dayton Journal: Ultrasound Med Biol Date: 2018-03-27 Impact factor: 2.998
Authors: James Shue-Min Yeh; Charles A Sennoga; Ellen McConnell; Robert Eckersley; Meng-Xing Tang; Sussan Nourshargh; John M Seddon; Dorian O Haskard; Petros Nihoyannopoulos Journal: PLoS One Date: 2015-07-10 Impact factor: 3.240